All News


Translating the promise

The controversy over embryonic stem cell research will not dissipate until the technology proves itself in the clinic. Now the regulators have to move, say Science|Business’s Nuala Moran.

Reading the runes for venture capital

Ireland’s largest-ever healthcare venture capital fund is making its optimistic debut as one of the UK’s longest-standing VC supporters of high tech start-ups calls it quits. So what’s happening?